IPO - ADIAL PHARMACEUTICALS, INC.

Form Type: CORRESP

Filing Date: 2024-12-26

Corporate Action: Ipo

Type: New

Accession Number: 000121390024112607

Filing Summary: Adial Pharmaceuticals, Inc. has submitted a request to the U.S. Securities and Exchange Commission to accelerate the effective date of its Registration Statement on Form S-1 (File No. 333-283968) to December 30, 2024, at 4:00 p.m. Eastern Time. This request indicates the company's eagerness to proceed with its initial public offering and serves as confirmation that it is aware of the responsibilities under federal securities laws regarding the issuance of the securities covered in the Registration Statement. The Registrant has authorized specific representatives from Blank Rome LLP to modify or withdraw this request if needed and has provided contact details for further communications regarding this matter.

Document Link: View Document